Report cover image

Global Antiretroviral Agent Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 109 Pages
SKU # APRC20354312

Description

Summary

According to APO Research, The global Antiretroviral Agent market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Antiretroviral Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Antiretroviral Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Antiretroviral Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Antiretroviral Agent include Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck Sharp and Dohme, ViiV Healthcare, AbbVie, GlaxoSmithKline and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiretroviral Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiretroviral Agent.

The Antiretroviral Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiretroviral Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Antiretroviral Agent Segment by Company

Boehringer Ingelheim
Bristol-Myers Squibb
Genentech
Gilead Sciences
Merck Sharp and Dohme
ViiV Healthcare
AbbVie
GlaxoSmithKline
Pfizer
Mylan
Janssen Pharmaceuticals

Antiretroviral Agent Segment by Type

Fusion Inhibitors
Entry Inhibitors—CCR5 Co-Receptor Antagonist
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
HIV Integrase Strand Transfer Inhibitors
Others

Antiretroviral Agent Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Others

Antiretroviral Agent Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiretroviral Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antiretroviral Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

109 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Antiretroviral Agent Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Antiretroviral Agent Sales Estimates and Forecasts (2020-2031)
1.3 Antiretroviral Agent Market by Type
1.3.1 Fusion Inhibitors
1.3.2 Entry Inhibitors—CCR5 Co-Receptor Antagonist
1.3.3 Nucleoside Reverse Transcriptase Inhibitors
1.3.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.3.5 Protease Inhibitors
1.3.6 HIV Integrase Strand Transfer Inhibitors
1.3.7 Others
1.4 Global Antiretroviral Agent Market Size by Type
1.4.1 Global Antiretroviral Agent Market Size Overview by Type (2020-2031)
1.4.2 Global Antiretroviral Agent Historic Market Size Review by Type (2020-2025)
1.4.3 Global Antiretroviral Agent Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Antiretroviral Agent Sales Breakdown by Type (2020-2025)
1.5.2 Europe Antiretroviral Agent Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Antiretroviral Agent Sales Breakdown by Type (2020-2025)
1.5.4 South America Antiretroviral Agent Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Antiretroviral Agent Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Antiretroviral Agent Industry Trends
2.2 Antiretroviral Agent Industry Drivers
2.3 Antiretroviral Agent Industry Opportunities and Challenges
2.4 Antiretroviral Agent Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Antiretroviral Agent Revenue (2020-2025)
3.2 Global Top Players by Antiretroviral Agent Sales (2020-2025)
3.3 Global Top Players by Antiretroviral Agent Price (2020-2025)
3.4 Global Antiretroviral Agent Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Antiretroviral Agent Major Company Production Sites & Headquarters
3.6 Global Antiretroviral Agent Company, Product Type & Application
3.7 Global Antiretroviral Agent Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Antiretroviral Agent Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antiretroviral Agent Players Market Share by Revenue in 2024
3.8.3 2023 Antiretroviral Agent Tier 1, Tier 2, and Tier 3
4 Antiretroviral Agent Regional Status and Outlook
4.1 Global Antiretroviral Agent Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Antiretroviral Agent Historic Market Size by Region
4.2.1 Global Antiretroviral Agent Sales in Volume by Region (2020-2025)
4.2.2 Global Antiretroviral Agent Sales in Value by Region (2020-2025)
4.2.3 Global Antiretroviral Agent Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Antiretroviral Agent Forecasted Market Size by Region
4.3.1 Global Antiretroviral Agent Sales in Volume by Region (2026-2031)
4.3.2 Global Antiretroviral Agent Sales in Value by Region (2026-2031)
4.3.3 Global Antiretroviral Agent Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Antiretroviral Agent by Application
5.1 Antiretroviral Agent Market by Application
5.1.1 Retail Pharmacies
5.1.2 Online Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Others
5.2 Global Antiretroviral Agent Market Size by Application
5.2.1 Global Antiretroviral Agent Market Size Overview by Application (2020-2031)
5.2.2 Global Antiretroviral Agent Historic Market Size Review by Application (2020-2025)
5.2.3 Global Antiretroviral Agent Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Antiretroviral Agent Sales Breakdown by Application (2020-2025)
5.3.2 Europe Antiretroviral Agent Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Antiretroviral Agent Sales Breakdown by Application (2020-2025)
5.3.4 South America Antiretroviral Agent Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Antiretroviral Agent Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Comapny Information
6.1.2 Boehringer Ingelheim Business Overview
6.1.3 Boehringer Ingelheim Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Antiretroviral Agent Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Comapny Information
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Antiretroviral Agent Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Genentech
6.3.1 Genentech Comapny Information
6.3.2 Genentech Business Overview
6.3.3 Genentech Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Genentech Antiretroviral Agent Product Portfolio
6.3.5 Genentech Recent Developments
6.4 Gilead Sciences
6.4.1 Gilead Sciences Comapny Information
6.4.2 Gilead Sciences Business Overview
6.4.3 Gilead Sciences Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gilead Sciences Antiretroviral Agent Product Portfolio
6.4.5 Gilead Sciences Recent Developments
6.5 Merck Sharp and Dohme
6.5.1 Merck Sharp and Dohme Comapny Information
6.5.2 Merck Sharp and Dohme Business Overview
6.5.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Sharp and Dohme Antiretroviral Agent Product Portfolio
6.5.5 Merck Sharp and Dohme Recent Developments
6.6 ViiV Healthcare
6.6.1 ViiV Healthcare Comapny Information
6.6.2 ViiV Healthcare Business Overview
6.6.3 ViiV Healthcare Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ViiV Healthcare Antiretroviral Agent Product Portfolio
6.6.5 ViiV Healthcare Recent Developments
6.7 AbbVie
6.7.1 AbbVie Comapny Information
6.7.2 AbbVie Business Overview
6.7.3 AbbVie Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AbbVie Antiretroviral Agent Product Portfolio
6.7.5 AbbVie Recent Developments
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Comapny Information
6.8.2 GlaxoSmithKline Business Overview
6.8.3 GlaxoSmithKline Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline Antiretroviral Agent Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments
6.9 Pfizer
6.9.1 Pfizer Comapny Information
6.9.2 Pfizer Business Overview
6.9.3 Pfizer Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Antiretroviral Agent Product Portfolio
6.9.5 Pfizer Recent Developments
6.10 Mylan
6.10.1 Mylan Comapny Information
6.10.2 Mylan Business Overview
6.10.3 Mylan Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Antiretroviral Agent Product Portfolio
6.10.5 Mylan Recent Developments
6.11 Janssen Pharmaceuticals
6.11.1 Janssen Pharmaceuticals Comapny Information
6.11.2 Janssen Pharmaceuticals Business Overview
6.11.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio
6.11.5 Janssen Pharmaceuticals Recent Developments
7 North America by Country
7.1 North America Antiretroviral Agent Sales by Country
7.1.1 North America Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Antiretroviral Agent Sales by Country (2020-2025)
7.1.3 North America Antiretroviral Agent Sales Forecast by Country (2026-2031)
7.2 North America Antiretroviral Agent Market Size by Country
7.2.1 North America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Antiretroviral Agent Market Size by Country (2020-2025)
7.2.3 North America Antiretroviral Agent Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Antiretroviral Agent Sales by Country
8.1.1 Europe Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Antiretroviral Agent Sales by Country (2020-2025)
8.1.3 Europe Antiretroviral Agent Sales Forecast by Country (2026-2031)
8.2 Europe Antiretroviral Agent Market Size by Country
8.2.1 Europe Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Antiretroviral Agent Market Size by Country (2020-2025)
8.2.3 Europe Antiretroviral Agent Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Antiretroviral Agent Sales by Country
9.1.1 Asia-Pacific Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Antiretroviral Agent Sales by Country (2020-2025)
9.1.3 Asia-Pacific Antiretroviral Agent Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Antiretroviral Agent Market Size by Country
9.2.1 Asia-Pacific Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Antiretroviral Agent Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Antiretroviral Agent Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Antiretroviral Agent Sales by Country
10.1.1 South America Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Antiretroviral Agent Sales by Country (2020-2025)
10.1.3 South America Antiretroviral Agent Sales Forecast by Country (2026-2031)
10.2 South America Antiretroviral Agent Market Size by Country
10.2.1 South America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Antiretroviral Agent Market Size by Country (2020-2025)
10.2.3 South America Antiretroviral Agent Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Antiretroviral Agent Sales by Country
11.1.1 Middle East and Africa Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Antiretroviral Agent Sales by Country (2020-2025)
11.1.3 Middle East and Africa Antiretroviral Agent Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Antiretroviral Agent Market Size by Country
11.2.1 Middle East and Africa Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Antiretroviral Agent Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Antiretroviral Agent Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Antiretroviral Agent Value Chain Analysis
12.1.1 Antiretroviral Agent Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Antiretroviral Agent Production Mode & Process
12.2 Antiretroviral Agent Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Antiretroviral Agent Distributors
12.2.3 Antiretroviral Agent Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.